Skip to main content
. 2018 Oct 18;2018(10):CD009431. doi: 10.1002/14651858.CD009431.pub3

de Groot 1997.

Methods Randomised. double‐blind. placebo‐controlled trial. Single‐centre. Criteria for FD: equivalent symptom to Rome with both type of FD
Participants N = 121
Female: 54%
Mean age: 40.9 years for the prokinetic group and 43.9 years for the placebo group
Country : the Netherlands
Interventions Intervention: cisapride 10 mg three times a day
Comparator: placebo
No rescue medication
Duration of treatment: 4 weeks
Outcomes Physician's assessment of overall result as on 4‐point scales (excellent, good, moderate, poor), data reported as excellent or good
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "Randomized"
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Double‐blinded
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Assessed by doctor but we do not know if he was blinded
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 7% not included in the analyses
Selective reporting (reporting bias) Unclear risk Combined excellent and good global response
Other bias Low risk No other risk found